Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Heart Failure

Free Subscription Articles published in Am J Cardiol Retrieve available abstracts of 276 articles: HTML format

Single Articles

October 2025
1. TIAN F, Hu C, Liu W, Zhang B, et al
   Noninvasive Right Ventricular Myocardial Work by Pressure-Strain Loop: A New Perspective on Right Ventricular Function and Cardiac Resynchronization Therapy.
   Am J Cardiol. 2025;252:8-15.
   PubMed     Abstract available
   
   
   September 2025
2. WANG J, Nouraie SM, Kelly NJ, Chan SY, et al
   Deep learning predicts cardiac output from seismocardiographic signals in heart failure.
   Am J Cardiol. 2025 Sep 30:S0002-9149(25)00593.
   PubMed     Abstract available
   
   
   
3. LIU B, Zhong Y, Yin X, Huang R, et al
   The Impact of Comorbidity Patterns on Clinical Outcomes in Heart Failure: A Machine Learning-Based Cluster Analysis.
   Am J Cardiol. 2025 Sep 28:S0002-9149(25)00598.
   PubMed     Abstract available
   
   
   
4. BUONO MGD, Saponara G, Sanna T
   Functional Capacity in Heart Failure: A Rising Tide Lifts All Boats.
   Am J Cardiol. 2025 Sep 26:S0002-9149(25)00581.
   PubMed    
   
   
   
5. PHERAI MS, de Jong FEI, Jansen J, Tukker M, et al
   Secondary Erythrocytosis in Patients with Heart Failure on SGLT2 inhibitors: Insights from a Multicenter "Real World" Study.
   Am J Cardiol. 2025 Sep 25:S0002-9149(25)00566.
   PubMed    
   
   
   
6. BUTT JH, Bundgaard JS, Schou M, Yafasova A, et al
   Implantable Cardioverter-Defibrillator And Frailty In Non-ischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up Of The DANISH Trial.
   Am J Cardiol. 2025 Sep 23:S0002-9149(25)00577.
   PubMed     Abstract available
   
   
   
7. KIM GY, Lim SM, Lee S, Sun BJ, et al
   Outcome of Functional Mitral Regurgitation Associated with Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
   Am J Cardiol. 2025 Sep 19:S0002-9149(25)00557.
   PubMed     Abstract available
   
   
   
8. VACEK JL
   Climbing to the Summit of Guideline Directed Therapy of Heart Failure: A Slippery Slope.
   Am J Cardiol. 2025 Sep 6:S0002-9149(25)00540.
   PubMed    
   
   
   
9. SCRUTINIO D, Guida P, Passantino A
   Interaction of risk of death and improvement in functional capacity after cardiac rehabilitation on Heart Failure prognosis.
   Am J Cardiol. 2025 Sep 3:S0002-9149(25)00517.
   PubMed     Abstract available
   
   
   
10. SILVESTRE J, Brgdar A, Chen J, Di Salvo TG, et al
    Increasing Rate of Unfilled Training Positions in the Advanced Heart Failure and Transplant Cardiology Match.
    Am J Cardiol. 2025 Sep 2:S0002-9149(25)00511.
    PubMed     Abstract available
    
    
    
11. KELLEY GA, Kelley KS, Stauffer BL
    Representation of Heart Failure Patients According to Age, Sex, and Race in US-Based Exercise Trials: A Systematic Review with Meta-Analysis of Randomized Trials.
    Am J Cardiol. 2025 Sep 2:S0002-9149(25)00532.
    PubMed    
    
    
    
12. QUINTANA-HAYASHI MP, Connolly K, Greasley P, Chan M, et al
    A Phase 1b Randomized Clinical Trial of AZD5642 and Dapagliflozin in Patients with Heart Failure and Moderate Renal Impairment.
    Am J Cardiol. 2025 Sep 2:S0002-9149(25)00510.
    PubMed     Abstract available
    
    
    August 2025
13. SEPHIEN A, Girgis JG, Reljic T, Dayto DC, et al
    Efficacy and Safety of Different Combinations of Add-on Diuretic Therapy in Acute Heart Failure: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Am J Cardiol. 2025 Aug 26:S0002-9149(25)00505.
    PubMed     Abstract available
    
    
    
14. ONO R, Falcao LM
    Coronary Artery Disease in Heart Failure with Preserved Ejection Fraction.
    Am J Cardiol. 2025 Aug 25:S0002-9149(25)00499.
    PubMed     Abstract available
    
    
    
15. HU Y, Li Y, Ma H, Sun L, et al
    Prevalence and Prognostic Differences Between Sarcopenia and Sarcopenic Obesity in Heart Failure.
    Am J Cardiol. 2025 Aug 21:S0002-9149(25)00494.
    PubMed     Abstract available
    
    
    
16. NIIZEKI T, Iwayama T, Sasaki T
    Prognostic Implications of Regional Cerebral Blood Flow Abnormality Assessed by Single Photon Emission Computed Tomography in Chronic Heart Failure Patients.
    Am J Cardiol. 2025 Aug 21:S0002-9149(25)00482.
    PubMed     Abstract available
    
    
    
17. VERELST FR, Zagorski B, Averbuch T, Bagur R, et al
    Long-term Healthcare Utilization and Outcomes in Patients Hospitalized for Heart Failure with and without Atrial Fibrillation.
    Am J Cardiol. 2025 Aug 20:S0002-9149(25)00479.
    PubMed     Abstract available
    
    
    
18. BASHIR Z, Saxena R, Khalife W, Jneid H, et al
    Predictors of Sodium Glucose Co-Transporter-2 Inhibitor utilization in Elderly Heart Failure Patients: A Real-World Population-Level Dataset Analysis.
    Am J Cardiol. 2025 Aug 19:S0002-9149(25)00487.
    PubMed     Abstract available
    
    
    
19. GIORGI J, Cristodulo R, Vaca C, Urena D, et al
    Clinical and Epidemiological Profile of Heart Failure Patients with Chagas Disease: Insights from the SEPE-HF Registry.
    Am J Cardiol. 2025 Aug 18:S0002-9149(25)00486.
    PubMed    
    
    
    
20. GEGENAVA T, Tukker M, Caliskan K, Hirsch A, et al
    Prognostic Value of Compact Myocardial Thinning in Patients With Left Ventricular Noncompaction.
    Am J Cardiol. 2025;249:51-58.
    PubMed     Abstract available
    
    
    
21. XIA H, Li J, Dong J
    Clinical Characteristics and Prognosis of Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease.
    Am J Cardiol. 2025 Aug 15:S0002-9149(25)00480.
    PubMed     Abstract available
    
    
    
22. HAMAD PHA, Sathian DB
    Critical Concerns Regarding Echocardiographic Pressure-Volume Loop Analysis and Clinical Conclusions in Heart Failure Reverse Remodeling.
    Am J Cardiol. 2025 Aug 2:S0002-9149(25)00449.
    PubMed    
    
    
    July 2025
23. AMIOKA M, Kinoshita H, Fuji Y, Nitta K, et al
    The Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Repeated Heart Failure Rehospitalizations among Elderly Patients with Acute Decompensated Heart Failure: The ROSES-HF Study.
    Am J Cardiol. 2025 Jul 12:S0002-9149(25)00404.
    PubMed     Abstract available
    
    
    
24. KLOSTER A, Sherafati A, Wunderly K, Aradhyula V, et al
    Oxylipins are Associated with Poor Right Ventricular to Pulmonary Artery Coupling and Adverse Outcomes in Heart Failure with Preserved Ejection Fraction.
    Am J Cardiol. 2025 Jul 1:S0002-9149(25)00390.
    PubMed     Abstract available
    
    
    June 2025
25. COLLUOGLU T, Akin Y
    Reader's Comments: Clinical Outcomes of Intravenous Iron Therapy in Systolic Heart Failure Patients Receiving Sodium-Glucose Cotransporter-2 Inhibitors.
    Am J Cardiol. 2025 Jun 27:S0002-9149(25)00387.
    PubMed    
    
    
    
26. DINI FL, Cioffi G, Carluccio E, Ghio S, et al
    Insights into the Benefits of Reverse Remodeling from an Echocardiographic Pressure/Volume Loop Model in Patients With Heart Failure Treated With Sacubitril/Valsartan.
    Am J Cardiol. 2025 Jun 20:S0002-9149(25)00372.
    PubMed     Abstract available
    
    
    
27. TAKEJI Y, Taniguchi T, Morimoto T, Shirai S, et al
    Early Aortic Valve Replacement Versus Clinical Surveillancein Asymptomatic Patients With Severe Aortic Stenosis.
    Am J Cardiol. 2025 Jun 7:S0002-9149(25)00360.
    PubMed     Abstract available
    
    
    
28. ALRUWAILI W, Ahmed S, Berzingi S, Atti L, et al
    Clinical Outcomes of Intravenous Iron Therapy in Systolic Heart Failure Patients Receiving SGLT2 Inhibitors.
    Am J Cardiol. 2025 Jun 6:S0002-9149(25)00362.
    PubMed     Abstract available
    
    
    
29. ADRICHEM R, Yang C, Geleijnse ML, van den Dorpel MMP, et al
    Transcatheter Aortic Valve Replacement for Patients with Moderate Aortic Stenosis - a Propensity Matched Analysis: TAVR vs clinical surveillance for moderate AS.
    Am J Cardiol. 2025 Jun 6:S0002-9149(25)00340.
    PubMed     Abstract available
    
    
    May 2025
30. AKBAR UA, Taha MB, Arshad HB, Patel KV, et al
    Young Adults Undergoing Percutaneous Coronary Intervention for Myocardial Infarction in the United States, 2011-2023.
    Am J Cardiol. 2025 May 10:S0002-9149(25)00295.
    PubMed     Abstract available
    
    
    
31. LIU X, Shen P, Chen Y, Sun Y, et al
    Incidence and Risk of Heart Failure in Patients with Coronary Heart Disease and Stroke: A Population-based Cohort Study.
    Am J Cardiol. 2025 May 6:S0002-9149(25)00286.
    PubMed     Abstract available
    
    
    
32. SCHAMROTH PRAVDA N, Richter I, Brem O, Yehuda D, et al
    Long Term Efficacy and Safety of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease Patients: A Single Center Cohort Study.
    Am J Cardiol. 2025;242:82-87.
    PubMed     Abstract available
    
    
    
33. HALL EJ, Ayers CR, Hendren NS, Clark C, et al
    Patient Characteristics, Management and Long-Term Outcomes of Patients With Cardiogenic Shock at a Large Safety Net Hospital.
    Am J Cardiol. 2025;242:10-17.
    PubMed     Abstract available
    
    
    April 2025
34. SOARES A, Park LK, Mansour E, Deych E, et al
    Predictive Value of V?O(2peak) in Adult Congenital Heart Disease in Comparison with Heart Failure with Reduced Ejection Fraction.
    Am J Cardiol. 2025 Apr 24:S0002-9149(25)00275.
    PubMed     Abstract available
    
    
    
35. MEGALY M, Zakhour S, Maki M, Albusoul L, et al
    Impact of Chronic Total Occlusion PCI in Non-LAD Coronary Arteries on Patients with Cardiomyopathy.
    Am J Cardiol. 2025 Apr 10:S0002-9149(25)00235.
    PubMed     Abstract available
    
    
    
36. HAYWOOD HB, Kaltenbach LA, Ikeaba U, Fonarow GC, et al
    Site-Level Variation and Factors Associated with an Outpatient Intravenous Diuretic Strategy for Worsening Heart Failure.
    Am J Cardiol. 2025 Apr 1:S0002-9149(25)00216.
    PubMed    
    
    
    March 2025
37. FAKESS S DO, Panza GA, Shaik A, Lico I, et al
    Incidence of Clinically Significant Ventricular Arrhythmias in Patients on Home Inotrope Infusion in the Contemporary Era: home inotrope and ventricular arrhythmias.
    Am J Cardiol. 2025 Mar 31:S0002-9149(25)00218.
    PubMed     Abstract available
    
    
    
38. GUIMARAES C, Gouveia R, Hipolito-Reis H, Ribeiro R, et al
    Right Ventricular Dysfunction in Heart Failure Patients: Does Sex Matter?
    Am J Cardiol. 2025 Mar 29:S0002-9149(25)00197.
    PubMed     Abstract available
    
    
    
39. SHEN Q, Clark L, Diaz F, Pierce J, et al
    Multidimensional Risk Factors for Heart Failure in Hispanic Adults: Findings from the All of Us Research Program.
    Am J Cardiol. 2025 Mar 11:S0002-9149(25)00147.
    PubMed     Abstract available
    
    
    
40. MUHAMMAD AN, Neppala S, Chigurupati HD, Ali A, et al
    Trends in Cardiac Arrest Among Heart Failure Patients Aged 25 and Older in the United States: Insights from the CDC WONDER Database: Cardiac Arrest Mortality Trends in Heart Failure.
    Am J Cardiol. 2025 Mar 9:S0002-9149(25)00137.
    PubMed    
    
    
    February 2025
41. MAUCH J, Puthenpura M, Martens P, Engelman T, et al
    Adequacy of Loop Diuretic Dosing in Treatment of Acute Heart Failure: Insights from the BAN-ADHF Diuretic Resistance Risk Score.
    Am J Cardiol. 2025 Feb 20:S0002-9149(25)00103.
    PubMed     Abstract available
    
    
    
42. ECHARTE-MORALES J, Cepas-Guillen P, Arzamendi D, Monivas V, et al
    One-Year Recurrent Tricuspid Regurgitation after Successful Transcatheter Edge to Edge Repair: the TRI-SPA Registry.
    Am J Cardiol. 2025 Feb 19:S0002-9149(25)00084.
    PubMed     Abstract available
    
    
    
43. CHAN N, Einstein AJ, Teruya S, Rodriguez C, et al
    The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations Study.
    Am J Cardiol. 2025;237:60-64.
    PubMed     Abstract available
    
    
    
44. MODUMUDI S, Reddy CP
    Comments on: "Cardiovascular Prognosis in Limb Ischemia Patients with Heart Failure and Systolic Dysfunction Following Major Amputation"?.
    Am J Cardiol. 2025 Feb 5:S0002-9149(25)00069.
    PubMed    
    
    
    
45. BYER SH, Sivamurugan A, Grewal US, Fradley MG, et al
    Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Cardiac Outcomes of SGLT2i on wt-ATTR-CM.
    Am J Cardiol. 2025 Feb 5:S0002-9149(25)00038.
    PubMed    
    
    
    January 2025
46. ASLANGER KE, Pamuk FO, Islamoglu Y, Ozates YS, et al
    Peripheral Venous Pressure-Guided Decongestive Therapy in Heart Failure 2 (PERIPHERAL-HF2).
    Am J Cardiol. 2025 Jan 22:S0002-9149(25)00044.
    PubMed     Abstract available
    
    
    
47. PATLOLLA SS, Alam AH, Katz JN, Hall SA, et al
    Tailored Therapy in Cardiogenic Shock: Case-Based Management Choices.
    Am J Cardiol. 2025;235:30-36.
    PubMed     Abstract available
    
    
    
48. PINTO G, Chiarito M, Puscas T, Bacher A, et al
    Comparative Influences of Beta blockers and Verapamil on Cardiac Outcomes in Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2025;235:9-15.
    PubMed     Abstract available
    
    
    
49. DE SCHUTTER S, Van Damme E, Van Hout G, Pype LL, et al
    Impact of Exercise on Atrial Functional Mitral Regurgitation and its Ddeterminants. An Exercise Echocardiographic Study.
    Am J Cardiol. 2025 Jan 10:S0002-9149(25)00001.
    PubMed     Abstract available
    
    
    
50. TAFCIU E, Pilan M, Rocca B, Minnucci I, et al
    The Impact of Right Atrial Function on Prognosis and Renal Function in Tricuspid Regurgitation Patients.
    Am J Cardiol. 2025 Jan 7:S0002-9149(25)00010.
    PubMed     Abstract available
    
    
    
51. ADUSUMALLI S, McCarthy CP, Magaret CA, Rhyne RF, et al
    Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions.
    Am J Cardiol. 2025 Jan 6:S0002-9149(25)00007.
    PubMed     Abstract available
    
    
    December 2024
52. TAKADA T, Shibahashi E, Hasegawa S, Yoshida A, et al
    Cardiovascular Prognosis in Limb Ischemia Patients with Heart Failure and Systolic Dysfunction Following Major Amputation.
    Am J Cardiol. 2024 Dec 31:S0002-9149(24)00896.
    PubMed     Abstract available
    
    
    
53. EDLUND J, Arvidsson PM, Nelsson A, Smith JG, et al
    Corrigendum to 'Non-Invasive Assessment of Left Ventricular Pressure-Volume Relations: Inter- and Intra-Observer Variability and Assessment Across Heart Failure Subtypes' [American Journal of Cardiology 184 (2022) 48-55].
    Am J Cardiol. 2024 Dec 19:S0002-9149(24)00860.
    PubMed    
    
    
    
54. OKITA S, Saito Y, Yaginuma H, Asada K, et al
    Patterns and Prognostic Impact of Post-Discharge Ischemic, Bleeding, and Heart Failure Events After Myocardial Infarction.
    Am J Cardiol. 2024 Dec 6:S0002-9149(24)00846.
    PubMed     Abstract available
    
    
    
55. ASHLEY SC, Khan MS, Greene SJ
    Clinical Course and Outcomes of Acute Heart Failure With Moderate-to-Severe Mitral or Tricuspid Regurgitation.
    Am J Cardiol. 2024 Dec 4:S0002-9149(24)00834.
    PubMed     Abstract available
    
    
    November 2024
56. GASECKA A, Jasinska-Gniadzik K, D'Ascenzo F, Angelini F, et al
    External Validation of COAPT Risk Score in Patients Undergoing Transcatheter Edge-To-Edge Repair of Severe, Functional Mitral Regurgitation: a Multicenter, Observational Italian-Polish Study.
    Am J Cardiol. 2024 Nov 27:S0002-9149(24)00820.
    PubMed     Abstract available
    
    
    
57. AUGUSTO SN JR, Wu Y, Chaikijurajai T, Hazen SL, et al
    Abbreviated Duke Activity Status Index for Risk Stratification in Heart Failure: Abbreviated Duke Activity Status Index.
    Am J Cardiol. 2024 Nov 25:S0002-9149(24)00829.
    PubMed     Abstract available
    
    
    
58. MALLIDI J, Baylis R, Song EJ
    Management of Cancer Therapy-Related Cardiac Dysfunction: A Case-Based Review.
    Am J Cardiol. 2024;231:20-31.
    PubMed     Abstract available
    
    
    October 2024
59. HOOD CJ, Gupta A, Hendren NS, Farr MA, et al
    Influence of Age on the Impact of a Natriuretic-Peptide Guided Treatment Strategy in Patients with Heart Failure.
    Am J Cardiol. 2024 Oct 29:S0002-9149(24)00764.
    PubMed    
    
    
    
60. SHCHENDRYGINA A, Mewton N, Niederseer D, Kida K, et al
    Cardiac Amyloidosis Screening and Management in Heart Failure with Preserved Ejection Fraction patients: an International Survey.
    Am J Cardiol. 2024 Oct 29:S0002-9149(24)00742.
    PubMed    
    
    
    
61. CZULADA E, Smith JD, Kolm P, Deb B, et al
    Rationale and design of OPT-RATE AF: A randomized clinical trial of increased physiologic pacing rates in heart failure with preserved ejection fraction.
    Am J Cardiol. 2024 Oct 18:S0002-9149(24)00727.
    PubMed     Abstract available
    
    
    
62. KRATKA A, Rohrbach G, Puckett C, Rotering TL, et al
    Implementation of a Cardiovascular Implantable Electronic Device Heart Failure Prediction Tool-Guided Management Pathway: CIED-Guided Heart Failure Management.
    Am J Cardiol. 2024 Oct 10:S0002-9149(24)00710.
    PubMed     Abstract available
    
    
    
63. IYER M, Ziada K, Cho L, Tamis-Holland J, et al
    Chronic Kidney Disease Predisposes to Acute Congestive Heart Failure, Cardiogenic Shock, and Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    Am J Cardiol. 2024 Oct 4:S0002-9149(24)00703.
    PubMed     Abstract available
    
    
    September 2024
64. REED GW, Harmon EK, Harb S, Yun J, et al
    Design and Rationale of the V-Wave Shunt MitraClip Study.
    Am J Cardiol. 2024;227:29-36.
    PubMed     Abstract available
    
    
    
65. TALHA KM, Hammonds K, Alhamdow A, Bennett MM, et al
    Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI Registry: Healthcare Utilization after Myocardial Infarction.
    Am J Cardiol. 2024 Sep 7:S0002-9149(24)00647.
    PubMed     Abstract available
    
    
    
66. KHAN MS, Ochani RK, Butler J
    Implications of diuretic use in contextualizing clinical trial results in patients with heart failure with preserved ejection fraction.
    Am J Cardiol. 2024 Sep 5:S0002-9149(24)00625.
    PubMed    
    
    
    
67. CHEN V, Davis BR, Kapadia SR, Kattan MW, et al
    Prevention of Heart Failure in Hypertension - the Role of Coronary Heart Disease Events Treated with Versus without Revascularization: the ALLHAT Study.
    Am J Cardiol. 2024 Sep 5:S0002-9149(24)00648.
    PubMed     Abstract available
    
    
    
68. KIM K, Murai R, Okada T, Toyota T, et al
    Incidence, time course, and outcomes of worsening tricuspid regurgitation following transvenous cardiac implantable electronic device implantation.
    Am J Cardiol. 2024 Sep 4:S0002-9149(24)00650.
    PubMed     Abstract available
    
    
    August 2024
69. ORIZU C, Jha M, Myerson L, Dong ZJ, et al
    Increased Aortic Stiffness with Acute Exercise in Heart Failure: Assessment by Cardiovascular Magnetic Resonance.
    Am J Cardiol. 2024 Aug 19:S0002-9149(24)00601.
    PubMed     Abstract available
    
    
    
70. SOARES C, Desai Y, Sorensen E, Dees L, et al
    Comparing Apixaban With Warfarin for Therapeutic Anticoagulation in Left Ventricular Assist Devices.
    Am J Cardiol. 2024;224:14-16.
    PubMed    
    
    
    July 2024
71. HARING B, Bohm M
    Heart Failure Prevention in Patients with Cancer: the Emerging Role of Screening for CHIP.
    Am J Cardiol. 2024 Jul 30:S0002-9149(24)00571.
    PubMed    
    
    
    
72. SHAH CH, Fonarow GC, Echouffo-Tcheugui JB
    Health Care Expenditure among US Adults with Heart Failure with and without Diabetes.
    Am J Cardiol. 2024 Jul 24:S0002-9149(24)00564.
    PubMed     Abstract available
    
    
    
73. MATASIC DS, Zeitoun R, Fonarow GC, Razavi AC, et al
    Advancements in Incident Heart Failure Risk Prediction & Screening Tools.
    Am J Cardiol. 2024 Jul 17:S0002-9149(24)00538.
    PubMed     Abstract available
    
    
    
74. KACHMAR M, Corpodean F, LaChute C, Popiv I, et al
    Clinical Outcomes of Metabolic Surgery on Diuretic Use in Patients with Heart Failure.
    Am J Cardiol. 2024 Jul 17:S0002-9149(24)00539.
    PubMed     Abstract available
    
    
    
75. MARSHALL V WH, Wright LK, Lampert BC, Salavitabar A, et al
    Invasive Implanted Hemodynamic Monitoring in Patients With Complex Congenital Heart Disease: State-of-the-Art Review.
    Am J Cardiol. 2024;223:123-131.
    PubMed     Abstract available
    
    
    
76. REYNOLDS MA, Golino M, West J, Talasaz AH, et al
    Depressive Symptoms and Functional Capacity in Participants with Recently Decompensated Heart Failure with Reduced Ejection Fraction.
    Am J Cardiol. 2024 Jul 13:S0002-9149(24)00515.
    PubMed    
    
    
    
77. KANG Y, Lefebvre B, Pamies IM, Gill SI, et al
    Symptomatic Heart Failure and Clonal Hematopoiesis-related Mutations in Patients with Acute Myeloid Leukemia.
    Am J Cardiol. 2024 Jul 5:S0002-9149(24)00476.
    PubMed     Abstract available
    
    
    
78. AGRONIN J, Brown M, Calvelli H, Zhao H, et al
    3-Year Left Ventricular Assist Device Outcomes and Strategy After Heart Transplant Allocation Score Change.
    Am J Cardiol. 2024 Jul 5:S0002-9149(24)00477.
    PubMed     Abstract available
    
    
    
79. FATH AR, Aglan M, Aglan A, Chilton RJ, et al
    Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study.
    Am J Cardiol. 2024;222:175-182.
    PubMed     Abstract available
    
    
    June 2024
80. ESATO M, Fujino A, Hamatani Y, Yoshizawa T, et al
    Association of Regression from Sustained to Paroxysmal Atrial Fibrillation with Clinical Outcomes: The Fushimi AF Registry.
    Am J Cardiol. 2024 Jun 25:S0002-9149(24)00456.
    PubMed     Abstract available
    
    
    
81. MANNINA C, Chopra L, Maenza J, Prandi FR, et al
    Left Ventricular Remodeling in Patients with Low Flow Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
    Am J Cardiol. 2024 Jun 24:S0002-9149(24)00455.
    PubMed     Abstract available
    
    
    
82. BRADY S, Matthia E, Antoine S, Aranda J, et al
    Outcome of Patients with Systolic Heart Failure Undergoing Sympathectomy for Ventricular Arrhythmia.
    Am J Cardiol. 2024 Jun 10:S0002-9149(24)00421.
    PubMed     Abstract available
    
    
    
83. NAGASAKA T, Shechter A, Patel V, Koren O, et al
    Two-year Clinical Outcomes of Staged Transcatheter Mitral Edge-to-Edge Repair after Transcatheter Aortic Valve Replacement.
    Am J Cardiol. 2024 Jun 4:S0002-9149(24)00413.
    PubMed     Abstract available
    
    
    May 2024
84. HIOKI H, Yamamoto M, Watanabe Y, Ohno Y, et al
    Size of Self-Expandable Transcatheter Heart Valve and Mid-Term Adverse Events After Transcatheter Aortic Valve Replacement.
    Am J Cardiol. 2024 May 24:S0002-9149(24)00371.
    PubMed     Abstract available
    
    
    
85. SHAHIM B, Cohen DJ, Asch FM, Bax J, et al
    Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair:The COAPT Trial.
    Am J Cardiol. 2024 May 22:S0002-9149(24)00395.
    PubMed     Abstract available
    
    
    
86. CHANG TW, Hung CL, Ko SL, Liao CT, et al
    Bridging the STRONG Gap: Call to Optimize Heart Failure Treatment after Hospitalization in Women and Men in Taiwan.
    Am J Cardiol. 2024 May 17:S0002-9149(24)00369.
    PubMed     Abstract available
    
    
    
87. SALEM M, Gada H, Ramlawi B, Sotelo M, et al
    Predictors of Disease Progression and Adverse Clinical Outcomes in Patients with Moderate Aortic Stenosis Using an Artificial Intelligence-Based Software Platform.
    Am J Cardiol. 2024 May 4:S0002-9149(24)00332.
    PubMed     Abstract available
    
    
    April 2024
88. GUPTA R, Bermudez F, Vora T, Homayouni N, et al
    Surveillance Imaging and Management of Cardiac Sarcoidosis after Advanced Heart Failure Therapies.
    Am J Cardiol. 2024 Apr 23:S0002-9149(24)00311.
    PubMed    
    
    
    
89. AHMED SI, Kenyon J, Billingsley HE, Salmons H, et al
    Corrigendum to 'Objectively Measured Night-Time Sleep Efficiency and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction' [American Journal of Cardiology 208 (2023) 124-125].
    Am J Cardiol. 2024 Apr 13:S0002-9149(24)00259.
    PubMed    
    
    
    
90. PAIVA L, Vieira MJ, Simoes M, Ferreira MJ, et al
    Unstable Angina Risk Stratification using High-sensitivity Cardiac Troponin and Coronary Angiography.
    Am J Cardiol. 2024 Apr 3:S0002-9149(24)00233.
    PubMed     Abstract available
    
    
    
91. MEKARY W, Merchant FM
    Multipoint Pacing for Cardiac Resynchronization: Is the MPP Juice Worth the Battery Squeeze?
    Am J Cardiol. 2024;216:98-99.
    PubMed    
    
    
    March 2024
92. SANTANA EJ, Christle JW, Cauwenberghs N, Peterman JE, et al
    Improving Reporting of Exercise Capacity Across Age Ranges Using Novel Workload Reference Equations.
    Am J Cardiol. 2024;215:32-41.
    PubMed     Abstract available
    
    
    
93. ILKHANOFF L, Atwater B, Barac A
    Atrial Fibrillation Amplifies Heart Failure Risk in Anthracycline Treated Cancer Patients: Stacking Risk Factors in the Vulnerable.
    Am J Cardiol. 2024 Mar 2:S0002-9149(24)00120.
    PubMed    
    
    
    
94. ROLDAN CA, Allen K, Ratliff M, Grodin J, et al
    Infective Endocarditis Complicated With a Large Left Coronary Cusp Aneurysm: A Condition With Undefined Natural History and Treatment.
    Am J Cardiol. 2024;214:105-108.
    PubMed     Abstract available
    
    
    
95. SHERAZI S, Patel A, Hsu K, Schleede S, et al
    Risk of Sudden Cardiac Death in Patients Undergoing Cancer Treatment.
    Am J Cardiol. 2024;214:136-141.
    PubMed     Abstract available
    
    
    
96. RUDZINSKI PN, Henzel J, Witkowski A, Dabrowski M, et al
    Transcatheter Intervention for Inoperable Tricuspid Surgical Prosthesis Dysfunction: Minimally Invasive Approach to Mitigate Heart Failure.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00154.
    PubMed    
    
    
    
97. SINGH S, Garg A, Tantry US, Bliden K, et al
    Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00161.
    PubMed     Abstract available
    
    
    February 2024
98. ARIAS-MENDOZA A, Gopar-Nieto R, Juarez-Tolen J, Ordonez-Olvera JC, et al
    Long Term Outcomes of Pharmacoinvasive Strategy vs. Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study From Mexico City.
    Am J Cardiol. 2024 Feb 23:S0002-9149(24)00113.
    PubMed     Abstract available
    
    
    
99. CHAMBERGO-MICHILOT D, Becerra-Gonzales VG, Kittipibul V, Colombo R, et al
    Racial Differences in Hospice Care Outcomes Among Patients with Advanced Heart Failure: Systematic Review and Meta-analysis.
    Am J Cardiol. 2024 Feb 19:S0002-9149(24)00096.
    PubMed     Abstract available
    
    
    
100. AGARWAL S, Qamar U, Fujiwara Y, Guha A, et al
     The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients with Cancer: A Systematic Review and Meta-Analysis.
     Am J Cardiol. 2024 Feb 17:S0002-9149(24)00101.
     PubMed    
     
     
     
101. PATEL L, Segar MW, Keshvani N, Subramanian V, et al
     Association of Beta Blocker Use with Exercise Capacity in Participants with Heart Failure with Preserved Ejection Fraction: A Post-Hoc Analysis of the RELAX Trial.
     Am J Cardiol. 2024 Feb 7:S0002-9149(24)00075.
     PubMed     Abstract available
     
     
     
102. SKEETE J, Huang HD, Mazur A, Sharma PS, et al
     Evolving Concepts in Cardiac Physiologic Pacing in the Era of Conduction System Pacing.
     Am J Cardiol. 2024;212:51-66.
     PubMed     Abstract available
     
     
     
103. MARON BJ, Rowin EJ, Maron MS
     Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
     Am J Cardiol. 2024;212S:S77-S82.
     PubMed     Abstract available
     
     
     
104. HUTT E, Desai MY
     Medical Treatment Strategies for Hypertrophic Cardiomyopathy.
     Am J Cardiol. 2024;212S:S33-S41.
     PubMed     Abstract available
     
     
     
105. BRAUNWALD E
     Hypertrophic Cardiomyopathy: A Brief Overview.
     Am J Cardiol. 2024;212S:S1-S3.
     PubMed     Abstract available
     
     
     January 2024
106. CELIK A, Sahin A, Ata N, Colluoglu IT, et al
     Navigating Heart Failure: Unveiling Sex Disparities in Guideline-Directed Medical Therapy Combinations.
     Am J Cardiol. 2024 Jan 22:S0002-9149(24)00063.
     PubMed     Abstract available
     
     
     
107. PASSAFARO F, Rapacciuolo A, Ruocco A, Ammirati G, et al
     COMPArison of Multi-Point Pacing and ConvenTional CRT Through Non-invasive Hemodynamics Measurement: Short and Long Term Results of the COMPACT-MPP Study.
     Am J Cardiol. 2024 Jan 16:S0002-9149(24)00034.
     PubMed     Abstract available
     
     
     
108. RAWLLEY B, Sanchez AC, Gupta K, Ramm M, et al
     Angiotensin Receptor/Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor Use in Patients With a Left Ventricular Assist Device: A Propensity Score Matched Analysis.
     Am J Cardiol. 2024;211:180-182.
     PubMed    
     
     
     
109. FU M, Wang Y, Han X, Yuan S, et al
     Revascularization for Patients With Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease.
     Am J Cardiol. 2024;213:86-92.
     PubMed     Abstract available
     
     
     
110. AL-SADAWI M, Gier C, Tao M, Henriques M, et al
     Risk of Appropriate Implantable Cardioverter-Defibrillator Therapies and Sudden Cardiac Death in Patients With Heart Failure With Improved Left Ventricular Ejection Fraction.
     Am J Cardiol. 2024;213:55-62.
     PubMed     Abstract available
     
     
     
111. RAO RA, Varghese SS, Ansari F, Rao A, et al
     The Role of Natriuretic Peptides in Predicting Adverse Outcomes After Cardiac Surgery: An Updated Systematic Review.
     Am J Cardiol. 2024;210:16-36.
     PubMed     Abstract available
     
     
     
112. PETERSON AN, Hickerson LC, Pschirrer ER, Friend LB, et al
     Management of Friedreich Ataxia-Associated Cardiomyopathy in Pregnancy: A Review of the Literature.
     Am J Cardiol. 2024;210:118-129.
     PubMed     Abstract available
     
     
     
113. DUE HT, Petersen JK, Havers-Borgersen E, Meulengracht DE, et al
     Mortality and Heart Failure Admission After Mitral Valve Surgery for Mitral Regurgitation in Patients With Versus Without a History of Atrial Fibrillation: A Nationwide Study.
     Am J Cardiol. 2024;210:177-182.
     PubMed     Abstract available
     
     
     December 2023
114. BRAGHIERI L, Younis A, Tabaja C, Santangeli P, et al
     Quality of Life Outcomes of Atrial Fibrillation Ablation in Heart Failure with Preserved or Mildly Reduced Left Ventricular Systolic Function.
     Am J Cardiol. 2023 Dec 29:S0002-9149(23)01414.
     PubMed    
     
     
     
115. KALANTARI S, Oren D, Medvedofsky D, Narang A, et al
     Corrigendum to 'Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure' [American Journal of Cardiology 210 (2024) 249-255].
     Am J Cardiol. 2023 Dec 19:S0002-9149(23)01405.
     PubMed    
     
     
     
116. D'ASCENZO F, Fabris E, Gregorio C, Mittone G, et al
     Corrigendum to 'Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score' [American Journal of Cardiology 206 (2023) 320-329].
     Am J Cardiol. 2023 Dec 16:S0002-9149(23)01390.
     PubMed    
     
     
     
117. LAENENS D, van der Bijl P, Galloo X, Rossi AC, et al
     Evolution of Echocardiography-Derived Hemodynamic Force Parameters After Cardiac Resynchronization Therapy.
     Am J Cardiol. 2023;209:138-145.
     PubMed     Abstract available
     
     
     
118. PALAZZUOLI A, Cartocci A, Pirrotta F, Tavera MC, et al
     Usefulness of Combined Ultrasound Assessment of E/e' Ratio, Pulmonary Pressure and Cava Vein Status in Patients with Acute Heart Failure.
     Am J Cardiol. 2023 Dec 15:S0002-9149(23)01376.
     PubMed     Abstract available
     
     
     
119. CARBONE S, Abbate A
     SGLT2 inhibitors in Patients Admitted for Acute Heart Failure: The Earlier the Better.
     Am J Cardiol. 2023 Dec 15:S0002-9149(23)01398.
     PubMed    
     
     
     
120. MARTENS P, Lewis GD, Mullens W, Tang WHW, et al
     Spontaneous Improvement in Iron Parameters and the Relation with changes in Functionality in Heart Failure.
     Am J Cardiol. 2023 Dec 15:S0002-9149(23)01385.
     PubMed    
     
     
     November 2023
121. SANNA GD
     Patient phenotype profiling in heart failure with reduced ejection fraction: a 'giant leap' - no longer postponable - for clinicians?
     Am J Cardiol. 2023 Nov 30:S0002-9149(23)01349.
     PubMed    
     
     
     
122. YONG JH, Mai AS, Matetic A, Elbadawi A, et al
     Cardiovascular Risk in Patients with Haematological Malignancies: A Systematic Review and Meta-Analysis of 1,960,144 cases.
     Am J Cardiol. 2023 Nov 30:S0002-9149(23)01331.
     PubMed     Abstract available
     
     
     
123. ONOUE T, Kang Y, Lefebvre B, Smith AM, et al
     Impact of atrial fibrillation on heart failure in patients treated with anthracycline chemotherapy.
     Am J Cardiol. 2023 Nov 18:S0002-9149(23)01332.
     PubMed     Abstract available
     
     
     
124. BARMAN HA, Dogan O, Tanyolac S, Atici A, et al
     Impact of Treatment with Sacubitril/Valsartan on Erectile Dysfunction in Patients with Heart Failure with Reduced Ejection Fraction.
     Am J Cardiol. 2023 Nov 18:S0002-9149(23)01316.
     PubMed     Abstract available
     
     
     
125. LUNDAHL C, Kragholm K, Tayal B, Karasoy D, et al
     Temporal Trends in Patient Characteristics and Outcomes of Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement: A Nationwide Study.
     Am J Cardiol. 2023 Nov 18:S0002-9149(23)01320.
     PubMed     Abstract available
     
     
     
126. VAN TASSELL B, Talasaz AH, Redlich G, Ziegelaar B, et al
     A Real-World Analysis of New-Onset Heart Failure After Anterior Wall ST-Elevation Acute Myocardial Infarction in the United States of America.
     Am J Cardiol. 2023 Nov 17:S0002-9149(23)01333.
     PubMed     Abstract available
     
     
     
127. SEPHIEN A, Dayto DC, Reljic T, Katz JN, et al
     Efficacy of Decision Aids in the Use of Left Ventricular Assist Device in Patients with Advanced Heart Failure: A Systematic Review and Meta-Analysis of Randomized Control Trials.
     Am J Cardiol. 2023 Nov 16:S0002-9149(23)01325.
     PubMed    
     
     
     
128. RUSNAK J, Schupp T, Weidner K, Ruka M, et al
     Outcome of Patients With Cardiogenic Shock and Previous Right Ventricular Impairment Represented by Decreased Tricuspid Annular Plane Systolic Excursion and Tricuspid Annular Plane Systolic Excursion to Pulmonary Artery Systolic Pressure Ratio.
     Am J Cardiol. 2023;207:431-440.
     PubMed     Abstract available
     
     
     
129. ARUNTHAMAKUN J, Patel PJ, Ravichandran AK
     The HFpEF Electrical Pathway Less Traveled?
     Am J Cardiol. 2023;207:497-498.
     PubMed    
     
     
     
130. ALMANI MU, Aliyev N, Qudrat-Ullah M, Khan MS, et al
     All-Cause and Cause-Specific 30-Day Readmissions After Left Ventricular Assist Device Implantation: Comparing the HeartMate 3 Versus Pre-HeartMate 3 Eras.
     Am J Cardiol. 2023;207:82-83.
     PubMed    
     
     
     
131. IMBURGIO S, Udongwo N, Mararenko A, Johal A, et al
     Impact of Frailty on Left Ventricular Assist Device Clinical Outcomes.
     Am J Cardiol. 2023;207:69-74.
     PubMed     Abstract available
     
     
     
132. VIRKUD AV, Chang PP, Funk MJ, Kshirsagar AV, et al
     Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
     Am J Cardiol. 2023;210:208-216.
     PubMed     Abstract available
     
     
     
133. YANG JW, Ma L, Zhang Z, Xiong R, et al
     Sound Touch Elastography for Noninvasive Assessment of Liver Stiffness in Patients With Chronic Heart Failure.
     Am J Cardiol. 2023 Nov 10:S0002-9149(23)01056.
     PubMed     Abstract available
     
     
     
134. YAN CL, Erben A, Sancassani R
     Evaluation of Inpatient Sodium-Glucose Co-Transporter-2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure.
     Am J Cardiol. 2023 Nov 7:S0002-9149(23)01293.
     PubMed     Abstract available
     
     
     
135. SANNA GD, Parodi G
     Atrial fibrillation and disproportionately low natriuretic peptides in heart failure.
     Am J Cardiol. 2023 Nov 2:S0002-9149(23)01256.
     PubMed    
     
     
     
136. ROMERO E, Baltodano AF, Rocha P, Sellers-Porter C, et al
     Clinical, Echocardiographic, and Longitudinal Characteristics Associated with Heart Failure with Improved Ejection Fraction.
     Am J Cardiol. 2023 Nov 1:S0002-9149(23)01261.
     PubMed     Abstract available
     
     
     October 2023
137. KALANATARI S, Oren D, Medvedofsky D, Narang A, et al
     Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure.
     Am J Cardiol. 2023 Oct 24:S0002-9149(23)01119.
     PubMed     Abstract available
     
     
     
138. DA SILVA EMF, Loureiro RM, Marinho RS, Marioti J, et al
     MITRAL ANNULAR EARLY DIASTOLIC VELOCITY HAS GOOD ACCURACY IN THE DETECTION OF LOW EXERCISE TOLERANCE IN PATIENTS WITH HEART FAILURE.
     Am J Cardiol. 2023 Oct 24:S0002-9149(23)01194.
     PubMed    
     
     
     
139. SMITH HR, Roberts LD, Witte KK
     It Is a Matter of Fat: The Obesity Paradox in Heart Failure.
     Am J Cardiol. 2023 Oct 23:S0002-9149(23)01136.
     PubMed    
     
     
     
140. RAV-ACHA M, Wube O, Brodie OT, Michowitz Y, et al
     Evaluation of Madit II Risk Stratification Score among Nationwide Registry of Heart Failure Patients with Primary Prevention Implantable Cardiac Defibrillators or Resynchronization Therapy Devices.
     Am J Cardiol. 2023 Oct 23:S0002-9149(23)01200.
     PubMed     Abstract available
     
     
     
141. AHMED H
     Reverse Remodeling in Heart Failure With Reduced Ejection Fraction Induced by Sacubitril-Valsartan: 3-Dimensional Echocardiography May Be a Useful Tool for the Future.
     Am J Cardiol. 2023 Oct 23:S0002-9149(23)01188.
     PubMed    
     
     
     
142. DONG B, Chen C, Zheng Y, Dong Y, et al
     Clinical implication of NT-proBNP burden in heart failure with reduced ejection fraction: from the GUIDE-IT.
     Am J Cardiol. 2023 Oct 22:S0002-9149(23)01202.
     PubMed     Abstract available
     
     
     
143. VASQUEZ MA, Iskander M, Mustafa M, Quintero-Martinez JA, et al
     Pericardiocentesis Outcomes in Patients with Pulmonary Hypertension: A Nationwide Analysis from the United States.
     Am J Cardiol. 2023 Oct 22:S0002-9149(23)01199.
     PubMed     Abstract available
     
     
     
144. ALBAENI A, Sharma M, Chatila KF, Shalaby M, et al
     Evaluation of Right-Side Filling Pressure in Patients With Obesity With Heart Failure Using Handheld Ultrasound Score.
     Am J Cardiol. 2023 Oct 19:S0002-9149(23)01107.
     PubMed     Abstract available
     
     
     
145. KUTALEK SP, Gupta A
     Can Rapid Atrial Pacing Mimic Exercise in Diagnosing Heart Failure With Preserved Ejection Fraction?
     Am J Cardiol. 2023 Oct 19:S0002-9149(23)00945.
     PubMed    
     
     
     
146. HU K
     Targeted Efforts Are Needed to Reduce the Short-Time Readmission Rate for Patients With Heart Failure as Primary and Secondary Diagnosis.
     Am J Cardiol. 2023 Oct 18:S0002-9149(23)01115.
     PubMed    
     
     
     
147. KATAOKA N, Imamura T
     Detailed Association Between Ventricular Arrhythmia, Right Ventricular Failure, and Clinical Outcomes in Patients Supported With Durable Left Ventricular Assist Device.
     Am J Cardiol. 2023 Oct 17:S0002-9149(23)01108.
     PubMed    
     
     
     
148. SAFIRIYU I, Mehta A, Mayowa A, Nagraj S, et al
     Incidence and Prognostic Implications of Cardiac-Implantable Device-Associated Tricuspid Regurgitation: A Meta-Analysis and Meta-Regression Analysis.
     Am J Cardiol. 2023 Oct 17:S0002-9149(23)01063.
     PubMed     Abstract available
     
     
     
149. KIM MJ, Aseltine RH Jr, Tabtabai SR
     Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities.
     Am J Cardiol. 2023 Oct 16:S0002-9149(23)01077.
     PubMed     Abstract available
     
     
     
150. IBRAHIM R, Shahid M, Tan MC, Martyn T, et al
     Exploring Heart Failure Mortality Trends and Disparities in Women: A Retrospective Cohort Analysis.
     Am J Cardiol. 2023 Oct 16:S0002-9149(23)01079.
     PubMed     Abstract available
     
     
     
151. ELKARYONI A, Saad M, Darki A, Abdelkarim I, et al
     Mitral Valve Transcatheter Edge-to-Edge Repair After TAVR: A Nationwide Analysis.
     Am J Cardiol. 2023 Oct 16:S0002-9149(23)01083.
     PubMed     Abstract available
     
     
     
152. KOURAMPI I, Katsioupa M, Oikonomou E, Tsigkou V, et al
     The Role of Ranolazine in Heart Failure-Current Concepts.
     Am J Cardiol. 2023 Oct 13:S0002-9149(23)01060.
     PubMed     Abstract available
     
     
     
153. SAKANE K, Kanzaki Y, Okuno T, Nakayama S, et al
     Left Atrial Remodeling Related to Disproportionately Low B-Type Natriuretic Peptide in Acute Heart Failure Patients with Atrial Fibrillation.
     Am J Cardiol. 2023 Oct 13:S0002-9149(23)01066.
     PubMed     Abstract available
     
     
     
154. NAGAI T, Horinouchi H, Hashimoto K, Ijichi T, et al
     Incremental Value of Global Longitudinal Strain for Confirming Heart Failure-Related Symptoms in Severe Aortic Stenosis.
     Am J Cardiol. 2023;209:1-7.
     PubMed     Abstract available
     
     
     
155. YAZDANYAR A
     Commentary on the Manuscript "Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission".
     Am J Cardiol. 2023 Oct 12:S0002-9149(23)01072.
     PubMed    
     
     
     
156. AHMED SI, Bohmke NJ, Kenyon J, Billingsley HE, et al
     Objectively Measured Night-Time Sleep Efficiency and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction.
     Am J Cardiol. 2023;208:124-125.
     PubMed    
     
     
     
157. AHMAD MI, Kazibwe R, Soliman MZ, Singh S, et al
     Joint Association of Albuminuria and Left Ventricular Hypertrophy With Incident Heart Failure in Adults at High Risk With Hypertension: A Systolic Blood Pressure Intervention Trial Substudy.
     Am J Cardiol. 2023;208:75-82.
     PubMed     Abstract available
     
     
     
158. DESAI U, Babcock A, Wang Y, Akbarnejad H, et al
     Real-World Incidence of Adverse Clinical Outcomes Among People With Coronary Artery Disease and/or Peripheral Artery Disease in Relation to Vascular Risk in the United States.
     Am J Cardiol. 2023;208:44-52.
     PubMed     Abstract available
     
     
     
159. MATHEW D, Sherif A
     Thirty-Day Readmission Rate and Hospitalization Costs With Heart Failure With Preserved Ejection Fraction and Obstructive Sleep Apnea.
     Am J Cardiol. 2023;208:4-5.
     PubMed    
     
     
     
160. NGUYEN HM, Mahabaleshwarkar R, Nandkeolyar S, Pokharel Y, et al
     Blood Pressure Control in a Diverse Population of Hypertensive Patients With Heart Failure.
     Am J Cardiol. 2023;208:25-30.
     PubMed     Abstract available
     
     
     
161. CHOPRA L, Ueyama H, Dalsania A, Prandi FR, et al
     Prognostic Implication of Pulmonary Hypertension in Low-Flow Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Replacement.
     Am J Cardiol. 2023;208:6-12.
     PubMed     Abstract available
     
     
     
162. FOX DK, Waken RJ, Wang F, Wolfe JD, et al
     The Association of the UNOS Heart Allocation Policy Change With Transplant and Left Ventricular Assist Device Access and Outcomes.
     Am J Cardiol. 2023;204:392-400.
     PubMed     Abstract available
     
     
     
163. NIROUMANDI S, Alavi R, Wolfson AM, Vaidya AS, et al
     Assessment of Aortic Characteristic Impedance and Arterial Compliance from Non-invasive Carotid Pressure Waveform in The Framingham Heart Study.
     Am J Cardiol. 2023;204:195-199.
     PubMed     Abstract available
     
     
     
164. DEERING TF, Reiffel JA, Solomon AJ, Tamirisa KP, et al
     Chapter 2: Rate Versus Rhythm Control.
     Am J Cardiol. 2023;205 Suppl 1:S7-S9.
     PubMed     Abstract available
     
     
     
165. DEERING TF, Reiffel JA, Solomon AJ, Tamirisa KP, et al
     Chapter 5: Guideline Recommendations: Which AAD and for Whom?
     Am J Cardiol. 2023;205 Suppl 1:S16-S18.
     PubMed     Abstract available
     
     
     September 2023
166. KIM MJ, Tabtabai SR, Aseltine RH Jr
     Predictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis.
     Am J Cardiol. 2023;207:407-417.
     PubMed     Abstract available
     
     
     
167. SCHAMROTH PRAVDA N, Richter I, Blieden L, Dadashev A, et al
     Long-Term Outcomes and Characteristics Associated With Mortality of Adult Patients Post Fontan Surgery: 27-Year Single-Center Experience.
     Am J Cardiol. 2023;207:392-398.
     PubMed     Abstract available
     
     
     
168. KRISHTOPAYTIS E, Ampnti SA, Obeidat M, Ramahi N, et al
     Can Inhaled Nitric Oxide Response Predict Tolerance to Therapies and Survival in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension?
     Am J Cardiol. 2023;207:363-369.
     PubMed     Abstract available
     
     
     
169. MIRZAI S, Persits I, Martens P, Chen PH, et al
     Significance of Adipose Tissue Quantity and Distribution on Obesity Paradox in Heart Failure.
     Am J Cardiol. 2023;207:339-348.
     PubMed     Abstract available
     
     
     
170. HUANG L, Zhao X, Liang L, Tian P, et al
     Obesity Paradox in Heart Failure Revisited: Etiology as Effect Modifier.
     Am J Cardiol. 2023;207:294-301.
     PubMed     Abstract available
     
     
     
171. DRAZNER MH
     Risk Stratification of Patients With Decompensated Heart Failure by Echocardiographic Assessment of Hemodynamics.
     Am J Cardiol. 2023;207:280-282.
     PubMed    
     
     
     
172. SIDDEGOWDA-BANGALORE B, Devaraj S, Rao RA, Jafri SH, et al
     No Evidence for Oversizing Hearts and Donor Size Impact on 1-Year Survival in Heart Failure Patients With Left Ventricular Assist Device.
     Am J Cardiol. 2023;207:215-221.
     PubMed     Abstract available
     
     
     
173. YAMAUCHI R, Morishima I, Okumura K, Kanzaki Y, et al
     Association Between Catheter Ablation for Nonparoxysmal Atrial Fibrillation and Functional Mitral Regurgitation in Patients With Heart Failure With Preserved Ejection Fraction.
     Am J Cardiol. 2023;207:192-201.
     PubMed     Abstract available
     
     
     
174. KADDOURA R, Bhattarai S, Abushanab D, Al-Hijji M, et al
     Percutaneous Mitral Valve Repair for Secondary Mitral Regurgitation: A Systematic Review and Meta-Analysis.
     Am J Cardiol. 2023;207:159-169.
     PubMed     Abstract available
     
     
     
175. ISMAIL TF
     Predicting 30-Day Readmission in Patients With Heart Failure-Primary Versus Secondary Diagnosis: Does It Matter?
     Am J Cardiol. 2023 Sep 20:S0002-9149(23)00980.
     PubMed    
     
     
     
176. IIDA M
     Aortic Valve Replacement in Patients With ESRD and Heart Failure With Reduced Ejection Fraction: The Worst Scenario, but There Remains a Hope.
     Am J Cardiol. 2023 Sep 19:S0002-9149(23)00858.
     PubMed    
     
     
     
177. TAKAHASHI T, Iwano H, Shibayama K, Kitai T, et al
     The Clinical Utility of Noninvasive Forrester Classification in Acute Heart Failure from PREDICT Study.
     Am J Cardiol. 2023;207:75-81.
     PubMed     Abstract available
     
     
     
178. D'ASCENZO F, Fabris E, DeGregorio C, Mittone G, et al
     Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score.
     Am J Cardiol. 2023;206:320-329.
     PubMed     Abstract available
     
     
     
179. GAN S, Zhao L, Salman O, Wang Z, et al
     Proteomic Correlates of the Urinary Protein/Creatinine Ratio in Heart Failure With Preserved Ejection Fraction.
     Am J Cardiol. 2023;206:312-319.
     PubMed     Abstract available
     
     
     
180. ONO R, Falcao LM
     Supra-Normal Left Ventricular Function.
     Am J Cardiol. 2023;207:84-92.
     PubMed     Abstract available
     
     
     
181. GARG M, Gupta M, Patel NN, Bansal K, et al
     Predictors and Outcomes of Sudden Cardiac Arrest in Heart Failure With Preserved Ejection Fraction: A Nationwide Inpatient Sample Analysis.
     Am J Cardiol. 2023;206:277-284.
     PubMed     Abstract available
     
     
     
182. ISHIBASHI T, Kaneko H, Ueno K, Morita K, et al
     Association Between Early Initiation of Cardiac Rehabilitation and Short-Term Outcomes of Patients With Acute Heart Failure Admitted to the Intensive Care Unit.
     Am J Cardiol. 2023;206:285-291.
     PubMed     Abstract available
     
     
     
183. JOY PS, Kumar G, Jermyn R, Van Zyl J, et al
     Heart Failure Admissions Outcomes in Patients With CardioMEMS.
     Am J Cardiol. 2023;207:7-9.
     PubMed    
     
     
     
184. SOKHAL BS, Matetic A, Abhishek A, Banerjee A, et al
     Impact of Frailty on Emergency Department Encounters for Cardiovascular Disease: A Retrospective Cohort Study.
     Am J Cardiol. 2023;206:210-218.
     PubMed     Abstract available
     
     
     
185. SPEARS J, Liskov S, Camm AJ, Kowey PR, et al
     How Antiarrhythmic Drugs Are Being Used in Patients With Heart Failure: Results of a Global Survey of Cardiologists.
     Am J Cardiol. 2023;206:60-62.
     PubMed    
     
     
     
186. MILLS RM
     Heart Failure With Preserved Ejection Fraction in Women: A Less "Cardio" and More "Vascular" Disease?
     Am J Cardiol. 2023 Sep 5:S0002-9149(23)00744.
     PubMed    
     
     
     
187. SINGH S, Goel S, Duhan S, Chaudhary R, et al
     Effect of Furosemide Versus Torsemide on Hospitalizations and Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
     Am J Cardiol. 2023;206:42-48.
     PubMed     Abstract available
     
     
     
188. SHIMONO Y, Ishizaka S, Omote K, Nakamura K, et al
     Impact of Cardiac Power Output on Exercise Capacity and Clinical Outcome in Patients With Chronic Heart Failure.
     Am J Cardiol. 2023;206:4-11.
     PubMed     Abstract available
     
     
     
189. FENG D, Ye Y, Li Z, Zhang B, et al
     Total Cholesterol Levels and Risk of Mortality or Heart Failure Rehospitalization in Patients With Valvular Heart Disease.
     Am J Cardiol. 2023;205:473-480.
     PubMed     Abstract available
     
     
     
190. HARRINGTON J, Sun JL, Fonarow GC, Heitner SB, et al
     Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart Failure.
     Am J Cardiol. 2023 Sep 2:S0002-9149(23)00776.
     PubMed    
     
     
     
191. CHACKO P, Bhuta S, Meenakshisundaram C, Moustafa A, et al
     Prevalence of Heart Failure With Preserved Ejection Fraction in Patients Undergoing Atrial Fibrillation Ablation Based on Resting and Post-Tachycardia Pacing Left Atrial Pressure.
     Am J Cardiol. 2023;205:445-450.
     PubMed     Abstract available
     
     
     August 2023
192. CIOFANI JL, Han D, Allahwala UK, Woolf B, et al
     Lipids, Blood Pressure, and Diabetes Mellitus on Risk of Cardiovascular Diseases in East Asians: A Mendelian Randomization Study.
     Am J Cardiol. 2023;205:329-337.
     PubMed     Abstract available
     
     
     
193. RAVANI LV, Gewehr DM, Calomeni P, Gauza MM, et al
     Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials.
     Am J Cardiol. 2023;205:259-268.
     PubMed     Abstract available
     
     
     
194. RAO A, Maini M, Seplowe M, Crowell NA, et al
     Health-Related Quality of Life in Patients with Advanced Heart Failure Receiving Continuous Intravenous Inotropic Support: A Multi-Center Survey.
     Am J Cardiol. 2023;205:231-233.
     PubMed    
     
     
     
195. WARNER ED, Riley J, Liotta M, Pritting C, et al
     Aortic Valve Replacement in Patients With ESRD and Heart Failure With Reduced Ejection Fraction.
     Am J Cardiol. 2023;205:111-119.
     PubMed     Abstract available
     
     
     
196. MICHELIS KC
     Finding the Sweet Spot in Predicting Risk for Hospitalized Patients With Heart Failure.
     Am J Cardiol. 2023 Aug 17:S0002-9149(23)00709.
     PubMed    
     
     
     
197. WANG DR, Li J, Parikh RV, Ziaeian B, et al
     Racial/Ethnic Disparities in Outcomes After Percutaneous Coronary Intervention.
     Am J Cardiol. 2023;205:120-125.
     PubMed     Abstract available
     
     
     
198. CROSIER R, Paquin A, Zhu T, Beanlands RS, et al
     Sex Differences in Systemic and Coronary Arterial Hemodynamics in Heart Failure With Preserved Ejection Fraction.
     Am J Cardiol. 2023;205:87-93.
     PubMed     Abstract available
     
     
     
199. SHIRAFKAN A, Gidea CG, Stein LH
     The Pulmonary System: A Different Sort of End Organ for Left Ventricular Assist Device Therapy.
     Am J Cardiol. 2023;201:372-373.
     PubMed    
     
     
     
200. DAMERA N, Shah C, George B, Chapa J, et al
     Using Sacubitril/Valsartan to Decrease Health care Costs in Population Health Patients.
     Am J Cardiol. 2023;201:142-147.
     PubMed     Abstract available
     
     
     
201. MOHAMED MS, Shehadah A, Hashem A, Chand S, et al
     Gastrointestinal Bleeding in Patients Supported with Left Ventricular Assist Devices: The Journey from Bridging to Destination.
     Am J Cardiol. 2023;201:71-77.
     PubMed     Abstract available
     
     
     
202. CELIKYURT U, Acar B, Agacdiken A, Vural A, et al
     Electrocardiographic Predictors of Complete Heart Block During Right Ventricular Lead Implantation in Patients Who Underwent Cardiac Resynchronization Therapy.
     Am J Cardiol. 2023;201:62-67.
     PubMed     Abstract available
     
     
     
203. GEORGE TJ, Sheasby J, Milligan G, Kabra N, et al
     Managing Right Ventricular Failure After Left Ventricular Assist Device Implant at a Destination Therapy Center.
     Am J Cardiol. 2023;201:1-7.
     PubMed     Abstract available
     
     
     
204. QIU W, Cai A, Xiao X, Gao Z, et al
     Association of Functional Tricuspid Regurgitation and All-Cause Mortality in Ischemic Heart Failure Varies by Left Atrial Size: A Prospective Cohort Study.
     Am J Cardiol. 2023;205:50-57.
     PubMed     Abstract available
     
     
     
205. MURPHY D, Firoozi S, Herzog CA, Banerjee D, et al
     Cardiac Troponin, Kidney Function, Heart Failure and Mortality After Myocardial Infarction in Patients With and Without Kidney Impairment.
     Am J Cardiol. 2023;204:383-391.
     PubMed     Abstract available
     
     
     
206. HIOKI H, Watanabe Y, Kataoka A, Kozuma K, et al
     Impact of Gender on Mortality After Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation.
     Am J Cardiol. 2023;205:12-19.
     PubMed     Abstract available
     
     
     
207. YAN CL, Gallo RA, Vasquez Martinez M, Rivera Rodriguez B, et al
     Safety and Efficacy of Traditional Heart Failure Therapies in Patients With Cardiac Amyloidosis and Heart Failure.
     Am J Cardiol. 2023;204:360-365.
     PubMed     Abstract available
     
     
     
208. ERKKILA O, Hernesniemi J, Tynkkynen J
     The Association Between Digoxin Use and Long-Term Mortality After Acute Coronary Syndrome.
     Am J Cardiol. 2023;204:377-382.
     PubMed     Abstract available
     
     
     
209. MADANAT L, Seeley E, Mando R, Shah K, et al
     Mortality Outcomes in Patients With Cardiac Implantable Electronic Devices Before and After Transcatheter Aortic Valve Replacement.
     Am J Cardiol. 2023;205:1-9.
     PubMed     Abstract available
     
     
     
210. VILLASCHI A, Pagnesi M, Stolfo D, Baldetti L, et al
     Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry.
     Am J Cardiol. 2023;204:268-275.
     PubMed     Abstract available
     
     
     
211. KAUL S, Siddiqi TJ, Anker SD, Butler J, et al
     Heart Failure Hospitalizations Versus Cardiovascular Mortality in Heart Failure Trials.
     Am J Cardiol. 2023 Aug 7:S0002-9149(23)00596.
     PubMed    
     
     
     
212. REKHTMAN D, Iyengar A, Song C, Weingarten N, et al
     Emerging Racial Differences in Heart Transplant Waitlist Outcomes for Patients on Temporary Mechanical Circulatory Support.
     Am J Cardiol. 2023;204:234-241.
     PubMed     Abstract available
     
     
     
213. PIERCE JB, Blumer V, Choi S, Hardy NC, et al
     Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naive to Renin-Angiotensin System Inhibitors.
     Am J Cardiol. 2023;204:151-158.
     PubMed     Abstract available
     
     
     
214. GOMEZ-RODRIGUEZ C, Tadeo-Espinoza H, Solis-Huerta F, Leal-Villarreal MAJ, et al
     Hemodynamic Evaluation of Right-Sided Congestion With Doppler Ultrasonography in Pulmonary Hypertension.
     Am J Cardiol. 2023;203:459-462.
     PubMed    
     
     
     
215. ZHANG W, He L, Zhang J, Fu G, et al
     Electrical Synchrony Optimization for Left Bundle Branch Area Pacing in Patients With Bradycardia and Heart Failure.
     Am J Cardiol. 2023;203:436-443.
     PubMed     Abstract available
     
     
     
216. HASHEM A, Khalouf A, Mohamed MS, Ismayl M, et al
     Outcomes of Percutaneous Atrial Septal Defect Closure With Mitral Transcatheter Edge-to-Edge Repair and Transseptal Mitral Valve Replacement (2015 to 2020).
     Am J Cardiol. 2023;204:92-95.
     PubMed     Abstract available
     
     
     
217. SEGAR MW, Zhang A, Paisley RD, Badjatiya A, et al
     Risk Stratification in Patients Who Underwent Percutaneous Left Atrial Appendage Occlusion.
     Am J Cardiol. 2023;200:50-56.
     PubMed     Abstract available
     
     
     
218. GOTSMAN I, Abu Ghosh Z, Zwas DR, Amir O, et al
     Pulmonary Hypertension Severity in Heart Failure: Clinical Characteristics and Impact on Outcome.
     Am J Cardiol. 2023;204:29-31.
     PubMed    
     
     
     
219. RAZZOLINI R
     Liver Fibrosis Biomarkers and Heart Failure: A Step Forward?
     Am J Cardiol. 2023 Aug 1:S0002-9149(23)00533.
     PubMed    
     
     
     July 2023
220. CHO MS, Cha MJ, Nam GB, Choi KJ, et al
     Incidence and Predictors of Severe Tricuspid Regurgitation in Atrial Fibrillation Patients Without Structural Heart Disease.
     Am J Cardiol. 2023;203:288-294.
     PubMed     Abstract available
     
     
     
221. GROBMAN B, Kothapalli N, Mansur A, Lu CY, et al
     Suicide Risk Among Patients With Heart Disease and Heart Failure.
     Am J Cardiol. 2023;203:259-264.
     PubMed     Abstract available
     
     
     
222. FARHAT K, Elkholey K, Asad ZUA, Stavrakis S, et al
     Atrial Myopathy and Ischemic Stroke in Heart Failure With Preserved Ejection Fraction.
     Am J Cardiol. 2023;203:248-252.
     PubMed     Abstract available
     
     
     
223. APPUNNI S, Rubens M, Ramamoorthy V, Saxena A, et al
     Adverse Outcomes in Hospitalizations for Amyloid-Related Heart Failure.
     Am J Cardiol. 2023;203:169-174.
     PubMed     Abstract available
     
     
     
224. SAMSON R, Le Jemtel TH
     Sacubitril-Valsartan in Heart Failure: The Hard Sell of Spending More to Save Later.
     Am J Cardiol. 2023 Jul 25:S0002-9149(23)00521.
     PubMed    
     
     
     
225. RIVERA-CARAVACA JM, Anguita Sanchez M, Sanmartin Fernandez M, Rafols C, et al
     Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment.
     Am J Cardiol. 2023;203:122-127.
     PubMed     Abstract available
     
     
     
226. KANEKO T, Kagiyama N, Nakamura Y, Dotare T, et al
     Usefulness of HANBAH Score in Japanese Patients With Acute Heart Failure.
     Am J Cardiol. 2023;203:45-52.
     PubMed     Abstract available
     
     
     
227. MASUDA M, Matsuda Y, Uematsu H, Sugino A, et al
     Gender Differences in Atrial Fibrosis and Cardiomyopathy Assessed by Left Atrial Low-Voltage Areas During Catheter Ablation of Atrial Fibrillation.
     Am J Cardiol. 2023;203:37-44.
     PubMed     Abstract available
     
     
     
228. HYLAND PM, Fleming LM
     Right-Sided Cardiac Failure After Destination-Therapy-Left Ventricular Assist Device: Where Do We Go from Here?
     Am J Cardiol. 2023 Jul 18:S0002-9149(23)00471.
     PubMed    
     
     
     
229. KIM CH, Sajgalik P, Schettle SD, Clavell AL, et al
     Pulmonary Capillary Recruitment Is Attenuated Post Left Ventricular Assist Device Implantation.
     Am J Cardiol. 2023;199:44-49.
     PubMed     Abstract available
     
     
     
230. SEPHIEN A, Dayto DC, Reljic T, Blonski W, et al
     A Systematic Critical Appraisal of Clinical Practice Guidelines in Heart Failure Using the AGREE II Tool.
     Am J Cardiol. 2023;202:192-198.
     PubMed     Abstract available
     
     
     
231. HAMZA M, Sattar Y, Manasrah N, Patel NN, et al
     Meta-Analysis of Efficacy and Safety of Intravenous Iron in Patients With Iron Deficiency and Heart Failure With Reduced Ejection Fraction.
     Am J Cardiol. 2023;202:119-130.
     PubMed     Abstract available
     
     
     
232. ZAHID S, Khan SU
     Time-Varying Cardiovascular Effects of Sodium-Glucose Cotransporter Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction.
     Am J Cardiol. 2023 Jul 6:S0002-9149(23)00451.
     PubMed    
     
     
     
233. MINHAS AMK, Bhopalwala HM, Dewaswala N, Ijaz SH, et al
     Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018).
     Am J Cardiol. 2023;202:41-49.
     PubMed     Abstract available
     
     
     
234. CHIMED S, Stassen J, Galloo X, Meucci MC, et al
     Prognostic Relevance of Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Reduced Ejection Fraction.
     Am J Cardiol. 2023;202:30-40.
     PubMed     Abstract available
     
     
     June 2023
235. GORDON J, Michelis KC, Pandey A, Ayers C, et al
     Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With Reduced Ejection Fraction.
     Am J Cardiol. 2023;201:273-280.
     PubMed     Abstract available
     
     
     
236. MOHAMAD ALAHMAD MA, Gupta K
     Undernutrition Severity Is Associated With Worse Outcomes in Patients With Acute Myocardial Infarction.
     Am J Cardiol. 2023;201:42-49.
     PubMed     Abstract available
     
     
     
237. TUSA M, Popolo Rubbio A, Sisinni A, Borin A, et al
     Prognostic Significance of Flail Mitral Leaflet in Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation.
     Am J Cardiol. 2023;200:178-187.
     PubMed     Abstract available
     
     
     
238. GALLOO X, Khidir M, Stassen J, Hirasawa K, et al
     Risk Factors for Short-Term Versus Long-Term Mortality in Patients Who Underwent Cardiac Resynchronization Therapy.
     Am J Cardiol. 2023;197:34-41.
     PubMed     Abstract available
     
     
     
239. RAMPA L, Santangelo R, Gaspardone C, Cerutti A, et al
     Potential Cardiologic Protective Effects of Acetylcholinesterase Inhibitors in Patients With Mild to Moderate Dementia.
     Am J Cardiol. 2023;200:162-170.
     PubMed     Abstract available
     
     
     
240. TADA A, Nagai T, Kato Y, Oyama-Manabe N, et al
     Prognostic Value of Liver Fibrotic Markers in Patients With Heart Failure.
     Am J Cardiol. 2023;200:115-123.
     PubMed     Abstract available
     
     
     
241. AKHTAR KH, Maqsood MH, Ansari SA, Siddiqi TJ, et al
     An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure.
     Am J Cardiol. 2023;200:32-39.
     PubMed     Abstract available
     
     
     
242. JIN G, Seong SW, Kim MJ, Ahn KT, et al
     Prevalence and Prognostic Implications of Worsening Renal Function After Acute Myocardial Infarction.
     Am J Cardiol. 2023;200:40-46.
     PubMed     Abstract available
     
     
     
243. KATTERLE KR, Niedoba MJ, Pasadyn VE, Mann A, et al
     Impact of Baseline Heart Failure on Acute Pulmonary Embolism Risk Stratification and Clinical Outcomes.
     Am J Cardiol. 2023;200:26-31.
     PubMed     Abstract available
     
     
     
244. MUKHERJEE M, Ogunmoroti O, Jani V, Kapoor K, et al
     Characteristics of Right Ventricular to Pulmonary Arterial Coupling and Association With Functional Status Among Older Aged Adults from the Multi-Ethnic Study of Atherosclerosis.
     Am J Cardiol. 2023;196:41-51.
     PubMed     Abstract available
     
     
     
245. ALHUARRAT MAD, Alhuarrat MR, Varrias D, Patel SR, et al
     Outcomes of Non-ST-Segment Myocardial Infarction During Chronic Heart Failure and End-Stage Renal Disease.
     Am J Cardiol. 2023;200:1-7.
     PubMed     Abstract available
     
     
     
246. FATIMA K, Asad D, Shaikh N, Ansari SA, et al
     A Systematic Review and Meta-Analysis on Effectiveness of Mineralocorticoid Receptor Antagonists in Reducing the Risk of Atrial Fibrillation.
     Am J Cardiol. 2023;199:85-91.
     PubMed     Abstract available
     
     
     May 2023
247. SCRUTINIO D, Guida P, Passantino A
     Prognostic Value of 6-Minute Walk Test in Advanced Heart Failure With Reduced Ejection Fraction.
     Am J Cardiol. 2023;199:37-43.
     PubMed     Abstract available
     
     
     
248. AMANO M, Izumi C, Watanabe H, Ozasa N, et al
     Effects of Long-Term Carvedilol Therapy in Patients With ST-Segment Elevation Myocardial Infarction and Mildly Reduced Left Ventricular Ejection Fraction.
     Am J Cardiol. 2023;199:50-58.
     PubMed     Abstract available
     
     
     
249. KIM H, Kim IC, Lee S
     Implications of the Mitral Leaflet Coaptation Pattern on Clinical Outcomes in Patients With Functional Mitral Regurgitation.
     Am J Cardiol. 2023;199:25-32.
     PubMed     Abstract available
     
     
     
250. NICHOLS GA, Qiao Q, Linden S, Kraus BJ, et al
     Medical Costs of Chronic Kidney Disease and Type 2 Diabetes Among Newly Diagnosed Heart Failure Patients With Reduced, Mildly Reduced, and Preserved Ejection Fraction.
     Am J Cardiol. 2023;198:72-78.
     PubMed     Abstract available
     
     
     
251. CHIMED S, Stassen J, Galloo X, Meucci MC, et al
     Corrigendum to 'Impact of Worsening Heart Failure on Long-Term Prognosis in Patients With Heart Failure With Reduced Ejection Fraction'.
     Am J Cardiol. 2023 May 16:S0002-9149(23)00278.
     PubMed    
     
     
     
252. HILL MC, Darbar D
     Slow and Steady Does Not Always Win the Race: Re-Evaluating Rate Control in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
     Am J Cardiol. 2023 May 13:S0002-9149(23)00245.
     PubMed    
     
     
     
253. AYUB MT, Rangavajla G, Thoma F, Mulukutla S, et al
     Relative Contribution of Atrial Fibrillation to Outcomes of Patients With Cardiomyopathy Based on Severity of Left Ventricular Dysfunction.
     Am J Cardiol. 2023;198:9-13.
     PubMed     Abstract available
     
     
     
254. JOGLAR JA
     Atrial Fibrillation and Heart Failure: Is It the Chicken or the Egg?
     Am J Cardiol. 2023 May 5:S0002-9149(23)00209.
     PubMed    
     
     
     
255. MEYER M, Wetmore JB, Weinhandl ED, Roetker NS, et al
     Association of Nondihydropyridine Calcium Channel Blockers Versus beta-Adrenergic Receptor Blockers With Risk of Heart Failure Hospitalization.
     Am J Cardiol. 2023 May 5:S0002-9149(23)00211.
     PubMed     Abstract available
     
     
     
256. KOERBER D, Khan S, Kirubarajan A, Spivak A, et al
     Meta-Analysis of Long-Term (>1 Year) Cardiac Outcomes of Peripartum Cardiomyopathy.
     Am J Cardiol. 2023;194:71-77.
     PubMed     Abstract available
     
     
     April 2023
257. LLOYD M, Amos ME, Milfred-Laforest S, Motairek IK, et al
     Residing in a Food Desert and Adverse Cardiovascular Events in US Veterans With Established Cardiovascular Disease.
     Am J Cardiol. 2023;196:70-76.
     PubMed     Abstract available
     
     
     
258. MICHELIS KC
     Cardiology Follow-Up Among Patients With Cancer and Patients Without Cancer Hospitalized for Heart Failure: Still Much Room for Improvement.
     Am J Cardiol. 2023 Apr 21:S0002-9149(23)00162.
     PubMed    
     
     
     
259. LOPEZ-VILELLA R, Jover Pastor P, Donoso Trenado V, Sanchez-Lazaro I, et al
     Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction.
     Am J Cardiol. 2023;196:59-66.
     PubMed     Abstract available
     
     
     
260. PATEL L, Lokesh N, Rao S, Powell-Wiley TM, et al
     Prevalence of Social Determinants Among US Residents With Heart Failure by Race/Ethnicity and Household Income.
     Am J Cardiol. 2023;196:38-40.
     PubMed    
     
     
     
261. WOLFE JD, Deych E, Sintek MA, Schilling JD, et al
     Hemodynamic Predictors of Stabilization When Using Temporary Mechanical Support for Cardiogenic Shock from Acute on Chronic Heart Failure.
     Am J Cardiol. 2023;195:83-90.
     PubMed     Abstract available
     
     
     
262. HIGGASON N, Soroka O, Goyal P, Mahmood SS, et al
     Suboptimal Cardiology Follow-Up Among Patients With and Without Cancer Hospitalized for Heart Failure.
     Am J Cardiol. 2023 Apr 3:S0002-9149(23)00123.
     PubMed     Abstract available
     
     
     
263. LING W, Jiang Z, Liu K, Zhang H, et al
     Effect of Vigileo/FloTrac System-Guided Aggressive Hydration in Acute Myocardial Infarction Patients to Prevent Contrast-Induced Nephropathy After Urgent Percutaneous Coronary Intervention.
     Am J Cardiol. 2023;195:77-82.
     PubMed     Abstract available
     
     
     
264. EGBE AC, Miranda WR, Stephens EH, Anderson JH, et al
     Right Ventricular Systolic Dysfunction in Adults With Anatomic Repair of d-Transposition of Great Arteries.
     Am J Cardiol. 2023;192:101-108.
     PubMed     Abstract available
     
     
     
265. PICCIRILLO F, Crispino SP, Buzzelli L, Segreti A, et al
     A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure.
     Am J Cardiol. 2023;195:57-69.
     PubMed     Abstract available
     
     
     March 2023
266. GOYAL P, Zhu A, Clarkson SA, Brown TM, et al
     Patient Awareness of Their Heart Failure Diagnosis and Its Implications for Epidemiologic Studies and Clinical Care.
     Am J Cardiol. 2023;195:27-30.
     PubMed    
     
     
     
267. QUINTERO-MARTINEZ JA, Dangl M, Uribe J, Vasquez MA, et al
     Impact of Chronic Heart Failure on Acute Pulmonary Embolism in-Hospital Outcomes (From a Contemporary Study).
     Am J Cardiol. 2023;195:17-22.
     PubMed     Abstract available
     
     
     
268. GOYAL A, Dalia T, Ranka S, Sauer AJ, et al
     Impact of Biopsy Proven Liver Fibrosis on Patients Undergoing Evaluation and Treatment for Advanced Heart Failure Surgical Therapies.
     Am J Cardiol. 2023;194:46-55.
     PubMed     Abstract available
     
     
     
269. OGAMI T, Kliner DE, Toma C, Sanon S, et al
     Acute Coronary Syndrome After Transcatheter Aortic Valve Implantation (Results from Over 40,000 Patients).
     Am J Cardiol. 2023;193:126-132.
     PubMed     Abstract available
     
     
     
270. ROBERTS WC, Jayanthi S, Jeong M
     Severe Heart Failure Resulting From Healed Myocardial Infarction Preferentially Involving the Ventricular Septum and Leading to Orthotopic Heart Transplantation.
     Am J Cardiol. 2023;193:111-117.
     PubMed     Abstract available
     
     
     
271. DIXON DD, Beussink-Nelson L, Deo R, Shah SJ, et al
     Differences in Cardiac Mechanics and Exercise Physiology Among Heart Failure With Preserved Ejection Fraction Phenomapping Subgroups.
     Am J Cardiol. 2023;193:102-110.
     PubMed     Abstract available
     
     
     
272. MUSSE M, Lau JD, Yum B, Pinheiro LC, et al
     Physician Perspectives on the Use of Beta Blockers in Heart Failure With Preserved Ejection Fraction.
     Am J Cardiol. 2023;193:70-74.
     PubMed     Abstract available
     
     
     
273. YASUI Y, Nakamura K, Omote K, Ishizaka S, et al
     Prognostic Significance of Peak Workload-to-Weight Ratio by Cardiopulmonary Exercise Testing in Chronic Heart Failure.
     Am J Cardiol. 2023;193:37-43.
     PubMed     Abstract available
     
     
     February 2023
274. ASLANGER E, Akaslan D, Atas H, Kocakaya D, et al
     Right Ventricular Energy Failure Predicts Mortality in Patients With Pulmonary Hypertension.
     Am J Cardiol. 2023;193:19-27.
     PubMed     Abstract available
     
     
     
275. AGARWAL S, Ul Abideen Asad Z, Akella K, Clifton S, et al
     Meta-Analysis on the Impact of Ventricular Arrhythmias on Mortality in Patients With Continuous Flow Left Ventricular Assist Devices.
     Am J Cardiol. 2023;192:139-146.
     PubMed     Abstract available
     
     
     
276. CHOUAIRI F, Miller PE, Loriaux DB, Katz JN, et al
     Trends and Outcomes in Cardiac Arrest Among Heart Failure Admissions.
     Am J Cardiol. 2023 Feb 1:S0002-9149(23)00013.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.